Notícias · Recifes

Get better sleep with ultrasound patch that boosts REM rest

A University of Texas at Austin-led team of researchers has developed a noninvasive patch that boosts REM sleep in real-world trials without surgery or medication. The technology, called NEUSLeeP, is a soft, wearable device that uses gentle ultrasound waves and electrodes to stim

Admin Recifes 15/07/2026 1

Clinical trial offers strong evidence that nerve blocks can cut opioid use after cardiac s

A clinical trial led by St. Michael's Hospital researchers found that using nerve blocks, an anesthesia technique to numb targeted areas of the body, significantly reduced opioid use after cardiac surgery—findings the authors say could reshape how the potentially addictive drugs

Admin Recifes 15/07/2026 1

Five-agent AI team could speed clinical trial design using real-world patient records

An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a new study by Weill Cornell Medicine investigators. The findings, published in N

Admin Recifes 15/07/2026 1

Electric fields could organize neural activity trial by trial during memory tasks

It's a fact of life that the electrical activity of neurons will vary during the same task, even when the ultimate outcome is the same. A new study shows that a lot of ongoing fluctuations in the brain's activity can be explained by the influence local electric fields exert on th

Admin Recifes 15/07/2026 2

Australian cancer trials are getting worse at reporting sex differences, putting patients

Women with cancer may not have the same chance of cure or quality of life as men—yet fewer than 2% of Australian cancer clinical trials report results separately for men and women. Women are also more likely to experience severe side effects from cancer treatment, including immun

Admin Recifes 15/07/2026 1

First randomized controlled trial shows promise of a ketogenic diet in psychotic disorders

Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The s

Admin Recifes 15/07/2026 1

Commonly used drugs show small benefit for long COVID fatigue

Over-the-counter antihistamines and a prescription anti-inflammatory drug both have a small benefit in reducing long COVID fatigue among people receiving care from specialist long COVID clinics, according to new findings from a large clinical trial led by UCL and UCLH.

Admin Recifes 15/07/2026 1

Moderate, home-based exercise found safe for aortic dissection survivors

A multicenter clinical trial led by UTHealth Houston has found that survivors of aortic dissection can participate in moderate-intensity exercise at home without increasing the risk of recurrent aortic events. The study is published in Circulation: Population Health and Outcomes.

Admin Recifes 15/07/2026 1

Eight-patient Parkinson's stem cell clinical trial confirms feasibility

A landmark study led by Lund, Sweden, has shown that transplanting stem cell-derived dopamine progenitor cells into the brain is feasible. Eight patients were transplanted in the first clinical trial, and no serious side effects linked to the transplanted cells were seen during t

Admin Recifes 15/07/2026 1

New clinical data advances stem cell-based cell therapy for Parkinson's disease

New clinical data from the STEM-PD Phase I/II clinical trial have been presented at the ISSCR 2026 Annual Meeting. The study reports 12-month outcomes evaluating a cryopreserved, off-the-shelf dopaminergic progenitor cell product derived from human pluripotent stem cells for the

Admin Recifes 15/07/2026 1

Data highlight progress toward personalized stem cell therapy for Parkinson's disease

Interim clinical findings from the first Phase I/IIa trial using autologous-induced pluripotent stem cell (iPSC)-derived dopamine neuron precursor cells, along with the novel quality-control tools developed to manufacture these individualized therapies, have been presented by Jea

Admin Recifes 15/07/2026 1

Huntington's treatment quest reaches first pluripotent stem cell trial, with safety now un

An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington's disease was presented at the ISSCR 2026 Annual Meeting. The Phase Ib/IIa REGEN4HD study represents a significant translational milestone following years of p

Admin Recifes 15/07/2026 1

Acompanhe as Notícias da Recifes